Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania - Concepedia

Concepedia

Publication | Open Access

Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania

DOI Full Paper Access

26

Citations

20

References

2021

Year

Sagal Mohamed, Happiness Mvungi, Margaretha Sariko, Prakruti Rao, Peter M. Mbelele, Erwin M. Jongedijk, C. Winkel, Daan J. Touw, Suzanne Stroup, Jan‐Willem C. Alffenaar,

Journal of Antimicrobial Chemotherapy

Abstract

Portable UV spectrophotometry as a point-of-care screen for subtarget levofloxacin exposure was feasible. Use for triage to other investigation or personalized dosing strategy should be tested in a randomized study.

References

	Year	Citations
pROC: an open-source package for R and S+ to analyze and compare ROC curves Xavier Robin, Natacha Turck, Alexandre Hainard, BMC Bioinformatics	2011	13.3K
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari Mase, Giovanni Battista Migliori, American Journal of Respiratory and Critical Care Medicine	2019	430
Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention Thi Van Anh Nguyen, Richard Anthony, Anne‐Laure Bañuls, Clinical Infectious Diseases New DrugMedicinal ChemistryMedicineNatural SciencesMolecular Biology	2017	187
Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis J. Peter Cegielski, Tracy Dalton, Martín Yagui, Clinical Infectious Diseases	2014	149
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis Devyani Deshpande, Jotam G. Pasipanodya, Stellah Mpagama, Clinical Infectious Diseases	2018	95
Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis Jan‐Willem C. Alffenaar, Tawanda Gumbo, Kelly E. Dooley, Clinical Infectious Diseases Systems PharmacologyTb PharmacologyPulmonary TuberculosisOperational ResearchTherapeutic Drug Monitoring	2019	88
Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis Won‐Jung Koh, Seung Heon Lee, Young Ae Kang, American Journal of Respiratory and Critical Care Medicine	2013	71
Sensititre MycoTB Plate Compared to Bactec MGIT 960 for First- and Second-Line Antituberculosis Drug Susceptibility Testing in Tanzania: a Call To Operationalize MICs Scott K. Heysell, Suporn Pholwat, Stellah Mpagama, Antimicrobial Agents and Chemotherapy Pulmonary TuberculosisDrug Susceptibility TestingHealth SciencesBactec Mgit 960Tuberculosis Prevention	2015	54
Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients Simone H.J. van den Elsen, Marieke G. G. Sturkenboom, Natasha van’t Boveneind-Vrubleuskaya, Antimicrobial Agents and Chemotherapy	2018	37
Plasma Drug Activity in Patients on Treatment for Multidrug-Resistant Tuberculosis Stellah Mpagama, Norah Ndusilo, Suzanne Stroup, Antimicrobial Agents and Chemotherapy	2013	37

Page 1